VFG
GSK icon

Victory Financial Group’s GSK GSK Stock Holding History

Victory Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$418K Sell
7,571
-3,046
-29% -$165K 0.05% 214
2025
Q4 		$521K Buy
10,617
+4,731
+80% +$221K 0.07% 183
2025
Q3 		$254K Buy
+5,886
New +$230K 0.03% 213

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Victory Financial Group's GSK Position: Q1 2026 in Review

Victory Financial Group reduced its GSK (GSK) stake by 29% in Q1 2026, selling an estimated $165K and leaving 7,571 shares worth $418K. The position accounts for 0.05% of the portfolio, ranked #214.

Victory Financial Group first reported a position in GSK in Q3 2025 and has held it in 3 quarters since. The position peaked at $521K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Victory Financial Group held 7,571 shares of GSK worth $418K as of Q1 2026.
  • Victory Financial Group sold 3,046 GSK shares in Q1 2026, an estimated $165K.
  • GSK made up 0.05% of Victory Financial Group's portfolio in Q1 2026, its #214 holding.
  • Victory Financial Group first reported a position in GSK in Q3 2025 and has held it in 3 quarters since.
  • Victory Financial Group's GSK position peaked at $521K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Victory Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.